| Literature DB >> 30683883 |
Clara Yongjoo Park1, Jiyoung Moon2, Garam Jo2, Juhee Lee2, Oh Yoen Kim3, Hannah Oh2, Hyunjung Lim4, Min-Jeong Shin5.
Abstract
The role of angiopoietin-like 3 (ANGPTL3) in blood lipid levels, cardiovascular disease risk, and glucose metabolism has received wide attention. This study aimed to examine whether rs11207997 in ANGPTL3 is associated with a 10-year risk of diabetes mellitus (DM) and if the association is modified by the consumption of certain food groups or nutrients. A prospective cohort study was designed using the Ansan-Ansung data of the Korean Genome and Epidemiology Study (n = 7,358; age ≥40 years at baseline). Participants with the T allele of rs11207997, particularly TT homozygotes, had lower triglyceride (TG) and total cholesterol levels than those with CC. There was no association with fasting blood glucose or other biochemical parameters. ANGPTL3 mRNA was positively associated with circulating TG levels and blood pressure (all p < 0.05). Cox proportional hazard models showed that the rs11207997 T allele is associated with a lower risk of DM after adjusting for covariates (hazard ratio: 0.90, 95% confidence interval: 0.812-0.998, p = 0.046). Furthermore, the association between rs11207997 and the risk of DM was modified by dietary factors. These associations were no longer statistically significant when additionally adjusted for baseline TG, a potential mediator. Our data suggest that genetic variation of rs11207997 in the ANGPTL3 gene is associated with risk of DM, possibly through contributing to a lifelong set point of TG.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30683883 PMCID: PMC6347602 DOI: 10.1038/s41598-018-36581-z
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Baseline characteristics of the study population.
| Total ( | 10-year follow-up | |||
|---|---|---|---|---|
| Healthy ( | Diabetes mellitus ( | |||
| Age, years | 51.6 ± 0.1 | 51.3 ± 0.1 | 53.1 ± 0.3 | <0.001 |
| Male, % (n) | 46.6 (3,427) | 45.4 (2,812) | 52.7 (615) | <0.001 |
| Area, % (n) | 0.001 | |||
| Ansung (rural) | 46.9 (3,452) | 47.7 (2,954) | 42.67 (498) | |
| Ansan (urban) | 53.1 (3,906) | 52.3 (3,236) | 57.4 (670) | |
| Body mass index, kg/m2 | 24.45 ± 0.04 | 24.29 ± 0.04 | 25.30 ± 0.09 | <0.001 |
| Total energy intake, kcal | 1957.6 ± 8.4 | 1962.2 ± 9.3 | 1933.5 ± 20.0 | 0.216 |
| Income level, % (n) | 0.993 | |||
| Lowest | 33.9 (2,450) | 33.8 (2,057) | 34.2 (393) | |
| Lower-middle | 29.4 (2,124) | 29.4 (1,787) | 29.3 (337) | |
| Upper-middle | 29.1 (2,103) | 29.2 (1,772) | 28.8 (331) | |
| Highest | 7.6 (548) | 7.6 (460) | 7.7 (88) | |
| Education level, % (n) | 0.389 | |||
| ≤Elementary school | 31.8 (2,316) | 31.4 (1,929) | 33.4 (387) | |
| ≤Middle school | 23.2 (1,692) | 23.4 (1,438) | 21.9 (254) | |
| ≤High school | 31.6 (2,305) | 31.8 (1,951) | 30.6 (354) | |
| ≥University | 13.4 (981) | 13.3 (818) | 14.1 (163) | |
| Current smoking, % (n) | 25.5 (1,848) | 25.0 (1,524) | 28.1 (324) | 0.025 |
| Current drinking, % (n) | 47.7 (3,474) | 47.1 (2,887) | 50.7 (587) | 0.024 |
| Metabolic equivalent, hours/day | 19.4 ± 0.2 | 19.4 ± 0.2 | 19.1 ± 0.5 | 0.531 |
| Biochemical markers | ||||
| SBP, mmHg | 120.4 ± 0.2 | 119.5 ± 0.2 | 125.2 ± 0.5 | <0.001 |
| DBP, mmHg | 79.8 ± 0.1 | 79.3 ± 0.1 | 82.5 ± 0.3 | <0.001 |
| TG, mg/dL§ | 151.5 ± 0.9 | 145.3 ± 0.9 | 184.8 ± 2.7 | <0.001 |
| TC, mg/dL | 189.8 ± 0.4 | 188.4 ± 0.4 | 197.3 ± 1.0 | <0.001 |
| HDLC, mg/dL | 45.0 ± 0.1 | 45.4 ± 0.1 | 43.0 ± 0.3 | <0.001 |
| LDLC, mg/dL | 115.0 ± 0.4 | 114.5 ± 0.4 | 118.3 ± 1.0 | <0.001 |
| FBG, mg/dL | 83.0 ± 0.1 | 82.0 ± 0.1 | 88.2 ± 0.3 | <0.001 |
| HbA1c, % | 5.571 ± 0.005 | 5.518 ± 0.004 | 5.855 ± 0.014 | <0.001 |
| HOMA-IR | 1.54 ± 0.01 | 1.51 ± 0.01 | 1.73 ± 0.03 | <0.001 |
| Genotype distribution | ||||
| rs11207997 | ||||
| CC/CT/TT, % | 60.8/34.3/4.9 | 60.3/34.7/5.0 | 63.4/32.1/4.5 | 0.149 |
| Minor allele frequency | 0.221 | 0.223 | 0.206 | |
Data are given as mean ± standard error or as percentages for continuous and categorical variables. Differences in the genotype were determined using Student’s t-test and chi-square tests. §Tested after log-transformation. DBP, diastolic blood pressure; FBG, fasting blood glucose; HDLC, high-density lipoprotein cholesterol; HOMA-IR, homeostatic model assessment of insulin resistance; LDLC, low-density lipoprotein cholesterol; SBP, systolic blood pressure; TC, total cholesterol; TG, triglyceride.
Clinical parameters of the population according to rs11207997 (ANGPTL3) genotype at baseline.
| rs11207997 | C/C ( | C/T ( | T/T ( | |
|---|---|---|---|---|
| SBP, mmHg ( | 120.5 ± 0.3 | 120.3 ± 0.4 | 121.1 ± 1.0 | 0.968 |
| DBP, mmHg ( | 79.8 ± 0.2 | 79.6 ± 0.2 | 80.3 ± 0.6 | 0.970 |
| TG, mg/dL§ ( | 154.6 ± 1.2a | 147.8 ± 1.5b | 140.5 ± 3.5b | <0.001 |
| TC, mg/dL ( | 190.2 ± 0.5a | 189.7 ± 0.7ab | 185.5 ± 1.7b | 0.029 |
| HDLC, mg/dL ( | 45.1 ± 0.2 | 45.0 ± 0.2 | 44. 8 ± 0.5 | 0.561 |
| LDLC, mg/dL ( | 114.8 ± 0.5 | 115.7 ± 0.6 | 113.0 ± 1.5 | 0.956 |
| FBG, mg/dL ( | 83.1 ± 0.1 | 82.9 ± 0.2 | 83.0 ± 0.5 | 0.749 |
| HbA1c, % ( | 5.58 ± 0.01 | 5.56 ± 0.01 | 5.57 ± 0.02 | 0.676 |
| HOMA-IR ( | 1.55 ± 0.01 | 1.54 ± 0.02 | 1.51 ± 0.04 | 0.769 |
Data are presented as mean ± standard error for clinical parameters. Differences among genotypes were determined by analysis of variance. Significance was tested using the generalized linear model with Bonferroni’s multiple comparisons after adjusting for age, sex, location, total energy intake, body mass index, physical activity, education level, and drinking status. §Tested after log-transformation. DBP, diastolic blood pressure; FBG, fasting blood glucose; HDLC, high-density lipoprotein cholesterol; HOMA-IR, homeostatic model assessment of insulin resistance; LDLC, low-density lipoprotein cholesterol; SBP, systolic blood pressure; TC, total cholesterol; TG, triglyceride.
Figure 1Relationship between ANGPTL3 mRNA expression (-ΔCt) and circulating triglyceride levels (mg/dL) or blood pressure (mmHg). r: correlation co-efficient; P: p-value. Data were tested by partial correlation analyses adjusted for age, sex, location, body mass index, total energy intake, physical activity, education level, and drinking status §log-transformed for the analysis.
Association between rs11207997 (ANGPTL3) polymorphism and diabetes occurrence.
| rs11207997 | Diabetes | |
|---|---|---|
| Case | 1,168 | |
| Total person-years | 43660.40 | |
| HR (95% CI) | 0.901 (0.812–0.998) | 0.046 |
Statistical differences were obtained by Cox regression analysis adjusted for age, sex, location, total energy intake, body mass index, physical activity, education level, smoking and drinking status. CI, confidence interval; HR, hazard ratio.
Stratification analysis by dietary factors for associations of rs11207997 genotype (ANGPTL3) with diabetes occurrence.
| Distribution for dietary risk factors | HR† | 95% CIs | |||||
|---|---|---|---|---|---|---|---|
|
| Mean | Median | Min | Max | |||
| Fruits (servings/week) | |||||||
| Q 1 | 1,839 | 3.5 | 3.6 | 0 | 6.51 | 0.828 | 0.656–1.038 |
| Q 2 | 1,838 | 9.6 | 9.6 | 6.52 | 13.00 | 0.795 | 0.644–0.980 |
| Q 3 | 1,841 | 16.9 | 16.8 | 13.00 | 21.42 | 1.139 | 0.942–1.377 |
| Q 4 | 1,840 | 32.8 | 28.6 | 21.43 | 147.00 | 0.825 | 0.676–1.005 |
| Vegetables (servings/week) | |||||||
| Q 1 | 1,839 | 22.8 | 24.8 | 0 | 32.57 | 0.823 | 0.663–1.021 |
| Q 2 | 1,840 | 39.2 | 39.3 | 32.57 | 45.32 | 0.793 | 0.643–0.978 |
| Q 3 | 1,839 | 52.2 | 51.8 | 45.34 | 60.43 | 1.050 | 0.867–1.272 |
| Q 4 | 1,840 | 82.6 | 74.3 | 60.44 | 310.65 | 0.927 | 0.758–1.134 |
| Whole grains (servings/week) | |||||||
| Q 1 | 1,834 | 0.1 | 0.0 | 0 | 0.29 | 0.920 | 0.742–1.141 |
| Q 2 | 1,830 | 3.0 | 2.0 | 0.29 | 7.38 | 0.916 | 0.738–1.137 |
| Q 3 | 1,796 | 10.7 | 10.6 | 7.40 | 13.94 | 0.865 | 0.714–1.048 |
| Q 4 | 1,898 | 20.2 | 21.0 | 14.00 | 43.50 | 0.888 | 0.729–1.082 |
| Unprocessed meat (servings/week) | |||||||
| Q 1 | 1,829 | 0.6 | 0.7 | 0 | 1.26 | 0.946 | 0.774–1.155 |
| Q 2 | 1,847 | 1.9 | 1.9 | 1.27 | 2.63 | 0.868 | 0.707–1.066 |
| Q 3 | 1,842 | 3.5 | 3.5 | 2.63 | 4.71 | 0.945 | 0.769–1.161 |
| Q 4 | 1,840 | 8.5 | 6.8 | 4.71 | 103.91 | 0.808 | 0.658–0.992 |
| Sodium (g/day) | |||||||
| Q 1 | 1,821 | 1.6 | 1.6 | 0.14 | 2.10 | 0.849 | 0.685–1.052 |
| Q 2 | 1,822 | 2.5 | 2.5 | 2.10 | 2.83 | 0.804 | 0.656–0.986 |
| Q 3 | 1,822 | 3.2 | 3.2 | 2.83 | 3.67 | 0.976 | 0.803–1.186 |
| Q 4 | 1,822 | 4.9 | 4.4 | 3.67 | 15.31 | 0.965 | 0.786–1.184 |
| Milk (servings/week) | |||||||
| Q 1 | 2,053 | 0 | 0 | 0 | 0 | 0.907 | 0.741–1.111 |
| Q 2 | 1,858 | 0.5 | 0.4 | 0.06 | 0.99 | 0.800 | 0.654–0.978 |
| Q 3 | 2,020 | 2.5 | 2.5 | 1.02 | 3.50 | 1.029 | 0.845–1.251 |
| Q 4 | 1,427 | 6.4 | 5.3 | 3.56 | 31.50 | 0.865 | 0.693–1.080 |
Statistical differences were obtained by Cox regression analysis. †Adjusted for age, sex, location, total energy intake, body mass index, physical activity, education level, and drinking status. CI, confidence interval; HR, hazard ratio; Q, quartile.
Figure 2Flow chart of study subject selection. CVD: cardiovascular disease, TG: triglyceride.